Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,625,908
-$809,331 QoQ
Shares Held
48,857
-2.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $77,931,464 across 17 Drug Manufacturers - General names. ABBV ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
303,856 | $36,550,838 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
48,857 | $10,625,908 | |
| 3 | JNJ |
Johnson & Johnson
|
41,381 | $10,115,171 | |
| 4 | LLY |
ELI LILLY & Co
|
6,998 | $6,436,550 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
73,108 | $4,434,000 | |
| 6 | PFE |
Pfizer Inc
|
79,856 | $2,242,356 | |
| 7 | AMGN |
Amgen Inc
|
5,229 | $1,839,823 | |
| 8 | AZN |
Astrazeneca PLC
|
6,722 | $1,325,712 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,625,908 | 48,857 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,435,239 | 50,047 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,560,118 | 54,246 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,645,326 | 25,026 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,548,391 | 12,163 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,802,766 | 10,145 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,475,174 | 7,470 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,197,209 | 6,980 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,057,636 | 5,808 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,263,159 | 8,151 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,273,865 | 8,546 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $831,013 | 6,168 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $963,710 | 6,047 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $941,539 | 5,826 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $832,504 | 6,203 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $911,761 | 5,953 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $1,023,400 | 6,313 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $853,967 | 6,307 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $665,881 | 6,173 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $664,350 | 5,898 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $489,139 | 4,565 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $389,863 | 4,451 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $429,832 | 4,378 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $343,007 | 4,502 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||